Cataract surgery under infliximab therapy in a patient with behet's disease

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 5, 2009, Pages 467-470

  Noda, Eriko ^a   Yamanishi, Shigeki ^a   Shiraishi, Atsushi ^a   Ohashi, Yuichi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; COLCHICINE; CYCLOSPORIN; GATIFLOXACIN; INFLIXIMAB; LEVOFLOXACIN; PREDNISOLONE;

ADULT; ARTICLE; BEHCET DISEASE; CASE REPORT; CATARACT EXTRACTION; HUMAN; HYPOPYON; IMMUNOSUPPRESSIVE TREATMENT; MALE; PERIOPERATIVE PERIOD; TREATMENT OUTCOME; UVEITIS;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; CATARACT; CATARACT EXTRACTION; DRUG ADMINISTRATION SCHEDULE; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; POSTOPERATIVE COMPLICATIONS; UVEITIS; VISUAL ACUITY;

EID: 70350440279     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0054     Document Type: Article

References (20)

1. Hiraoka, M., and Fujino, Y. Cataract surgery and intraocular lens implantation in patients with Behcet's disease. Nippon Ganka Gakkai Zasshi. 103:119-123, 1999.
2. Pivetti Pezzi, P., Gasparri, V., De Liso, P., et al. Prognosis in Behcet's disease. Ann. Ophthalmol. 17:20-25, 1985.
3. Kadayifcilar, S., Gedik, S., Eldem, B., et al. Cataract surgery in patients with Behcet's disease. J. Cataract. Refract. Surg. 28:316-320, 2002.
4. Sullu, Y., Oge, I., and Erkan, D. The results of cataract extraction and intraocular lens implantation in patients with Behcet's disease. Acta. Ophthalmol. Scand. 78:680-683, 2000.
5. Krause, L., Altenburg, A., Bechrakis, N.E., et al. Intraocular surgery under systemic interferon-alpha therapy in ocular Adamantiades-Behcet's disease. Graefes Arch. Clin. Exp. Ophthalmol. 245:1617-1621, 2007.
6. Foster, C.S., Fong, L.P., and Singh, G. Cataract surgery and intraocular lens implantation in patients with uveitis. Ophthalmology. 96:281-288, 1989.
7. Loewenstein, A., Bracha, R., and Lazar, M. Intraocular lens implantation in an eye with Behcet's uveitis. J. Cataract. Refract. Surg. 17:95-97, 1991.
8. Berker, N., Soykan, E., Elgin, U., et al. Phacoemulsification cataract extraction and intraocular lens implantation in patients with Behcet's disease. Ophthalmic. Surg. Lasers Imaging. 35:215-218, 2004.
9. Ohn, S., Nakamura, S., Hori, S., et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis. J. Rheumatol. 31:1362-1368, 2004.
10. Sfikakis, P.P., Theodossiadis, P.G., Katsiari, C.G., et al. Effect of infliximab on sight-threatening panuveitis in Behcet's disease. Lancet. 358:295-296, 2001.
11. Gul, A. Behcet's disease: an update on the pathogenesis. Clin. Exp. Rheumatol. 19:S6-S12, 2001.
12. Ahn, J.K., Yu, H.G., Chung, H., et al. Intraocular cytokine environment in active Behcet uveitis. Am. J. Ophthalmol. 142:429-434, 2006.
13. Evereklioglu, C., Er, H., Turkoz, Y., et al. Serum levels of TNFalpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated lipid peroxidation in patients with Behcet's disease. Mediators. Inflamm. 11:87-93, 2002.
14. Tanaka, T., Minoda, H., Kazuka, T., et al. Outcome of Surgery for complicated cataract in Bechet disease. Rinsho. Ganka (Jpn. J. Clin. Ophthalmol). 54(4):577-580, 2000.
15. Keane, J., Gershon, S., Wise, R.P., et al. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098-1104, 2001.
16. Giles, J.T., Bartlett, S.J., Gelber, A.C., et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis. Rheum. 55:333-337, 2006.
17. Colombel, J.F., Loftus, E.V., Jr., Tremaine, W.J., et al. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am. J. Gastroenterol. 99:878-883, 2004.
18. Ruyssen-Witrand, A., Gossec, L., Salliot, C., et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin. Exp. Rheumatol. 25:430-436, 2007.
19. Mor, I.J., Vogel, J.D., da Luz Moreira A, et al. Infliximab in ulcerative colitis is associated with an increased risk of postoperative complications after restorative proctocolectomy. Dis. Colon. Rectum. 51:1202-1207; discussion 1207-1210, 2008.
20. Shiozawa, K., Tanaka, Y, Yoshihara, R., et al. Rheumatic Diseases Center, Konan Kakogawa Hospital, Department of Rheumatology, Kobe University FHS School of Medicine. Treatment with infliximab improves the sequelae of arthroplasty in patients with rheumatoid arthritis. Clin. Rheumatol. 19:151-157, 2007.